Free Trial
LON:ONT

Oxford Nanopore Technologies (ONT) Share Price, News & Analysis

GBX 92.30
-4.20 (-4.35%)
(As of 12:37 PM ET)
Today's Range
92.30
97.45
50-Day Range
92.75
114.33
52-Week Range
91.24
279
Volume
1.68 million shs
Average Volume
1.08 million shs
Market Capitalization
£796.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
GBX 303.75

Oxford Nanopore Technologies MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
229.1% Upside
GBX 303.75 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
£2.54 M Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.19 out of 5 stars

ONT stock logo

About Oxford Nanopore Technologies Stock (LON:ONT)

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company operates in Life Science Research Tools and Covid Testing segments. It offers MinION, a portable device for DNA and RNA; GridION, a flexible and self-contained benchtop nanopore sequencer to run and analyse up to five MinION or Flongle flow cells; MinION Mk 1C, a nano pore-based sequencer with analysis software and connectivity for self-contained and portable sequencing; Flongle, an adapter for MinION or GridION that enables DNA sequencing or cDNA sequencing on smaller and single-use flow cells; and PromethION 2 Solo, a sequencer for two PromethION flow cells. The company also provides PromethION 2, a self-contained benchtop nanopore sequencer; PromethION 24, which provides single or multiple users with access to terabases of sequencing data; PromethION 48, a sequencing device with high-output flow cells; VolTRAX, an automated library prep for nanopore analyses; and Q-Line, a sequencing for applied applications, as well as products for SAR-Cov-2 testing. Its platform enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies plc in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is headquartered in Oxford, the United Kingdom.

ONT Stock Price History

ONT Stock News Headlines

My election-year investing secret
My election-year investing secret There's only one approach I trust when things look uncertain...
My election-year investing secret
My election-year investing secret There's only one approach I trust when things look uncertain...
Oxford Nanopore Technologies PLC ADR
Oxford Nanopore Technologies PLC ONTTF
ONTTF Oxford Nanopore Technologies plc
Revenue injection booster for Oxford Nanopore
Oxford Nanopore Technologies plc (ONT.L)
See More Headlines
Receive ONT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oxford Nanopore Technologies and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
1,238
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 303.75
High Stock Price Target
GBX 355
Low Stock Price Target
GBX 210
Potential Upside/Downside
+213.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
£-154,510,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£169.67 million
Cash Flow
GBX 24 per share
Book Value
GBX 75 per share

Miscellaneous

Free Float
N/A
Market Cap
£836.28 million
Optionable
Not Optionable
Beta
0.64
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Dr. Gurdial Singh Sanghera (Age 63)
    Co-Founder, CEO & Non-Executive Director
    Comp: $1.59M
  • Mr. Timothy Cowper (Age 59)
    COO & Director
    Comp: $894.98k
  • Dr. James Spike Willcocks
    Chief Strategy Officer & Director
  • Prof. Hagan Bayley Ph.D.
    Co-Founder & Member of Technical Advisory Board
  • Mr. Nicholas Patrick Keher (Age 42)
    CFO & Director
  • Mr. Jordan Herman
    Senior VP & General Counsel
  • Mr. John Schoellerman
    Senior Vice President of Corporate & Business Development
  • Mr. Richard Compton
    Senior Vice President of Sales & Commercial Operations
  • Ms. Sara Agee Le
    Vice President of Global Marketing
  • Ms. Sarah Lapworth
    Senior Vice President of Global Human Resources

ONT Stock Analysis - Frequently Asked Questions

Should I buy or sell Oxford Nanopore Technologies stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Oxford Nanopore Technologies in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ONT shares.
View ONT analyst ratings
or view top-rated stocks.

What is Oxford Nanopore Technologies' stock price target for 2024?

5 Wall Street analysts have issued twelve-month price targets for Oxford Nanopore Technologies' shares. Their ONT share price targets range from GBX 210 to GBX 355. On average, they anticipate the company's share price to reach GBX 303.75 in the next year. This suggests a possible upside of 229.1% from the stock's current price.
View analysts price targets for ONT
or view top-rated stocks among Wall Street analysts.

How have ONT shares performed in 2024?

Oxford Nanopore Technologies' stock was trading at GBX 208.20 on January 1st, 2024. Since then, ONT shares have decreased by 55.7% and is now trading at GBX 92.30.
View the best growth stocks for 2024 here
.

How do I buy shares of Oxford Nanopore Technologies?

Shares of ONT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:ONT) was last updated on 6/21/2024 by MarketBeat.com Staff

From Our Partners